This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Aug;37(8):1782.

doi: 10.1002/mds.29136.

Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?

Matthew Surface¹, Manisha Balwani², Cheryl Waters¹, Alexander Haimovich¹, Ziv Gan-Or^{3

4

5}, Karen S Marder¹, Tammy Hsieh^{6

7}, Linxia Song^{6

7}, Shalini Padmanabhan⁸, Frank Hsieh^{6

7}, Kalpana M Merchant⁸, Roy N Alcalay^{1

9}

Affiliations

Affiliations

¹ Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
² Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
³ The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.
⁴ Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
⁵ Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
⁶ Nextcea, Inc, Woburn, Massachusetts, USA.
⁷ The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
⁸ Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
⁹ Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

PMID: 35980035
DOI: 10.1002/mds.29136

Comment

Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?

Matthew Surface et al. Mov Disord. 2022 Aug.

. 2022 Aug;37(8):1782.

doi: 10.1002/mds.29136.

Authors

Matthew Surface¹, Manisha Balwani², Cheryl Waters¹, Alexander Haimovich¹, Ziv Gan-Or^{3

4

5}, Karen S Marder¹, Tammy Hsieh^{6

7}, Linxia Song^{6

7}, Shalini Padmanabhan⁸, Frank Hsieh^{6

7}, Kalpana M Merchant⁸, Roy N Alcalay^{1

9}

Affiliations

¹ Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
² Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
³ The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.
⁴ Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
⁵ Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
⁶ Nextcea, Inc, Woburn, Massachusetts, USA.
⁷ The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
⁸ Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
⁹ Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

PMID: 35980035
DOI: 10.1002/mds.29136

No abstract available

PubMed Disclaimer

Comment on

Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease.
Surface M, Balwani M, Waters C, Haimovich A, Gan-Or Z, Marder KS, Hsieh T, Song L, Padmanabhan S, Hsieh F, Merchant KM, Alcalay RN. Surface M, et al. Mov Disord. 2022 Feb;37(2):416-421. doi: 10.1002/mds.28846. Epub 2021 Nov 6. Mov Disord. 2022. PMID: 34741486 Free PMC article.
Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?
Kopytova AE, Usenko TS, Baydakova GV, Nikolaev MA, Senkevich KA, Izyumchenko AD, Tyurin AA, Miliukhina IV, Emelyanov AK, Zakharova EY, Pchelina SN. Kopytova AE, et al. Mov Disord. 2022 Aug;37(8):1779-1781. doi: 10.1002/mds.29132. Epub 2022 Jul 6. Mov Disord. 2022. PMID: 35792565 No abstract available.

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information